Find out more about Roy Kong's experience
Roy Kong's highlights
FEATURED Journal article
Inhibitory Effects of 3',4'-Dihydroxyflavonol in a Mouse Model of Glaucoma Filtration Surgery and TGFβ1-Induced Responses in Human Tenon's Fibroblasts.
Read moreRoy Kong's selected work
Comparison of the in vitro efficacy of OCX063 with Tranilast in RPE cells
Research Contracts
Transcriptomic analysis of choroidal neovascularization reveals dysregulation of immune an..
Journal article
Oral delivery of the anti-fibrotic, FT011, achieves safe and robust intraocular levels of ..
Conference Proceedings
OCX063, a novel small molecule drug, is protective against inflammatory, fibrotic and angi..
Conference Proceedings
Oral administration of the novel small molecule drug OCX063 protects against inflammation ..
Conference Proceedings
OCX063, A Novel Small Molecule Drug, Exhibits Anti-Inflammatory and Anti-Fibrotic Properti..
Conference Proceedings
Roy Kong's selected work
Projects
Displaying the 7 most recent projects from 7 for Roy Kong.
Project Types
7
Research Contracts
Scholarly Works
Displaying the 10 most recent scholarly works from 13 for Roy Kong.
Honours, Awards and Fellowships
Harold Mitchell Foundation Travel Fellowship
Melbourne Abroad Travelling Scholarship
Florey Student Top-up Scholarship
Melbourne International Research Scholarship
Melbourne International Fee Remission Scholarship
Credentials
Positions
Research Fellow
Medicine - St Vincent's Hospital
Member
Ausbiotech
Member
Association for Research in Vision and Ophthalmology
Member
The Australasian Society of Clincal and Experimental Pharmacologists and Toxicologists
Education
Doctor of Philosophy
University of Melbourne
Bachelor of Science (Degree with Honours)
University of Melbourne
Bachelor of Science
University of Melbourne